Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 03, 2021

SELL
$47.25 - $65.16 $945 - $1,303
-20 Closed
0 $0
Q3 2020

Oct 30, 2020

BUY
$46.35 - $61.69 $927 - $1,233
20 New
20 $1,000
Q1 2020

May 14, 2020

SELL
$32.73 - $50.78 $3,272 - $5,078
-100 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$6.81 - $39.55 $681 - $3,954
-100 Reduced 50.0%
100 $4,000
Q3 2019

Nov 14, 2019

BUY
$6.47 - $8.96 $1,294 - $1,792
200 New
200 $1,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.